Related references
Note: Only part of the references are listed.Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells
In-Kyung Jeong et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
The Effects of Palmitate on Hepatic Insulin Resistance Are Mediated by NADPH Oxidase 3-derived Reactive Oxygen Species through JNK and p38MAPK Pathways
Dan Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance
Giovanni Tarantino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Suppression of pro-inflammatory adhesion molecules by PPAR-δ in human vascular endothelial cells
Yanbo Fan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Activation of peroxisome proliferator-activated receptor β/δ inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-κB activity via extracellular signal-related kinase 1/2
Ricardo Rodriguez-Calvo et al.
DIABETES (2008)
PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis
Grant D. Barish et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes
Swati joshi-Barve et al.
HEPATOLOGY (2007)
Obesity, inflammation, and insulin resistance
Steven E. Shoelson et al.
GASTROENTEROLOGY (2007)
PGC-1α:: a key regulator of energy metabolism
Huiyun Liang et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2006)
Insulin resistance: A metabolic pathway to chronic liver disease
E Bugianesi et al.
HEPATOLOGY (2005)
Inflammation, stress, and diabetes
KE Wellen et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
PPARs: therapeutic targets for metabolic disease
JP Berger et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
SH Koo et al.
NATURE MEDICINE (2004)
Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes
M Fasshauer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
PPARs and the complex journey to obesity
RM Evans et al.
NATURE MEDICINE (2004)
Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome
T Tanaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
J Lin et al.
NATURE (2002)
A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
WR Oliver et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone
Y Miyazaki et al.
DIABETES CARE (2001)
Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1
LF Michael et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
